Interstitial lung disease, nephrotic syndrome and junctional epidermolysis bullosa is an autosomal recessive multiorgan disorder caused by mutations in the gene for the integrin α3 subunit (ITGA3). The full spectrum of manifestations and genotype-phenotype correlations is still poorly characterized. Here, we uncovered the disease-causing role and the molecular mechanisms underlying a homozygous ITGA3 mutation leading to the single amino acid substitution, p.R463W. The patient suffered from respiratory distress and episodes of cyanosis with onset in the first week of life and had a nephrotic syndrome. Although there was no clinical evidence for cutaneous fragility, the analysis of a skin sample and of skin epithelial cells enabled the direct assessment of the authentic mutant protein. We show that the mutation altered the conformation of the extracellular β-propeller domain of the integrin α3 subunit preventing correct processing of N-linked oligosaccharides, heterodimerization with β1 integrin and maturation through cleavage into heavy and light chains in the Golgi. Confocal microscopy demonstrated that the mutant protein accumulated intracellularly, but it was not present in focal adhesions or on the cell membrane as shown by flow cytometry. These findings highlight that single amino acid changes in the integrin α3 subunit may crucially alter the structure and complex processing of this integrin, completely preventing its functionality. The present report also underscores that ITGA3 mutations may account for atypical cases solely with early onset respiratory and renal involvement.
Introduction
Loss-of-function mutations of the integrin α3 subunit were recently associated with interstitial lung disease, nephrotic syndrome and junctional epidermolysis bullosa (ILNEB, OMIM 614748) in four cases (1, 2) (Table 1) ; nonetheless, the genotypephenotype correlations and the underlying disease mechanisms receptors also control cell survival, proliferation and differentiation, and display unique and redundant functions in tissues (6) , rendering the molecular disease mechanisms highly complex.
Integrin α3 subunit is widely expressed in epithelia, including lung epithelium, in kidney podocytes and skin epidermis (7) . Initially, constitutive and organ-specific knockout mouse models shed light on the consequences of loss of this subunit in vivo. Integrin α3 knockout mice die within 24 h after birth, because of defects in kidney and/or lung organogenesis (8) . They demonstrate abnormalities of the renal architecture regarding the formation of the collecting system, the proper growth and maintenance of proximal tubules and the capillary loops. Podocytes fail to differentiate are decreased in number and demonstrate a dramatic absence of foot process formation (8) . Mice with podocyte specific deletion of Itga3 display similar anomalies-foot process effacement, severe proteinuria and end-stage renal disease (9) . In contrast, deletion of the α3 subunit exclusively in the developing collecting duct resulted in only a mild developmental phenotype (9) . Mice with cell-specific loss of integrin α3 in alveolar epithelial cells had grossly preserved alveolar architecture and normal total lung capacity and airway resistance; in this model, α3 deficiency prevented the progression of fibrosis after bleomycin treatment (10) . Finally, the constitutive and epidermal-specific Itga3 knockout mice display microblistering at the dermal-epidermal junction and basement membrane (BM) duplication (11) (12) (13) . In the skin of these mice, loss of integrin α3 affects proper organization and stabilization of the epidermal BM (11, 13) , but not epidermal morphogenesis (14, 15) .
Here, we uncovered the disease-causing role of a single amino acid substitution, p.R463W, in the extracellular β-propeller domain of integrin α3 in a patient with fatal lung disease and congenital nephrotic syndrome, and demonstrate that defective posttranslational modification of integrin α3 prevents its incorporation and function at the cell membrane. Illumination of the biological consequences of this naturally occurring human mutation contributes to the understanding of the function and structure of integrin α3.
Results
Clinical and morphological findings A 14-day-old male patient was admitted to hospital with respiratory distress and episodes of cyanosis. The child was born at 40 weeks of pregnancy, with no health complications, weighing 3000 g, and was discharged from the hospital at the same time as his mother. Seven days after delivery, respiratory distress and episodes of cyanosis developed and he was referred to our department because of respiratory distress requiring continuous oxygen. The parents reported second degree consanguinity.
Physical examination detected pallor and poor weight gain, and tachypnea with a respiratory rate of 64 min −1 and intercostal retraction. Transcutaneous oxygen saturation was 84% in room air and respiratory auscultation detected bilateral crepitation. Results of full blood counts were within normal range. Chest radiography showed bilateral diffuse interstitial infiltrates (Fig. 1A) . Although he received ampicillin and gentamycin because of suspected congenital pneumonia, clinical findings were not improved. Chest computed tomography revealed diffuse ground glass opacity and interlobular septal thickening consistent with diffuse interstitial lung disease (Fig. 1B) . Mycoplasma pneumonia and Chlamydia pneumonia serology was negative. Flexible bronchoscopy did not reveal any pathological findings. Cytomegalovirus (CMV) polymerase chain reaction (PCR) in bronchoalveolar lavage fluid was 512 copies/ml; however, the blood CMV PCR was negative. Immunoglobulins and lymphocyte subsets were in normal range. Laboratory tests at 6 weeks of age indicated nephrotic-range proteinuria and hypoalbuminemia. Abdominal ultrasonography showed crossed fused renal ectopia. Blood and urine culture were negative. Broad-spectrum antibiotic and antifungal therapies and ganciclovir were used to treat pneumonia, but there was no improvement of the clinical and radiological findings. Lung biopsy was performed at the age of 2 months and revealed abnormal alveolarization, manifesting as enlarged, round and poorly septated ('simplified') alveolar spaces ( Fig. 2A) . This finding was consistent with alveolar growth disorder. Some other areas showed thickening of interalveolar septa and there was one pneumocyte with CMV inclusion (Fig. 2B) . During the clinical observation, he developed severe respiratory distress and required endotracheal intubation and mechanical ventilation for 2 weeks, from which he was successfully weaned. Laboratory tests at 3 months of the age indicated nephrotic-range proteinuria again. Renal biopsy was planned, but it was not performed because of crossed fused renal ectopia. Respiratory distress persisted during his followup and he required supplemental oxygen to maintain oxygen saturation values at a level >90%.
Methylprednisolone treatment was started at 2 mg/kg/day due to suspicion of interstitial lung disease, as there was no improvement, the steroid therapy was tapered day by day. From the age of 5 months, the infant had fine sparse scalp hair, mild thickening of the toenails (Fig. 3A) and growth retardation.
All these clinical, radiological and pathological findings suggested an integrin α3-associated disease. After informed consent, skin biopsy and EDTA-blood were obtained and submitted to molecular diagnostics, and he was discharged from the hospital at the age of 6 months with oxygen treatment. After hospital discharge, the infant died at the age of 6.5 months during an episode of pulmonary infection at another center. 
Disease-causing mutation and its biological consequences
To elucidate the underlying molecular defect, the skin biopsy was submitted to immunofluorescence antigen mapping as described before (1). Although clinically, no skin blistering was noticed, a junctional split was observed in the skin sample of the patient, as well as the lack of immunoreactivity for integrin α3 with the antibody P1B5, which stained at the periphery of basal keratinocytes in control skin (Fig. 3B) . Immunostaining of integrin α6 was noted at the blister roof in the patient's skin, with a similar intensity as in the control skin (Fig. 3B ). Based on these findings, ITGA3 mutation analysis was performed and a homozygous variant, c.1387C>T, p.R463W (in respect to NM_002204.2, NC_000017.11) was identified in the patient, which was present in a heterozygous state in each of the parents (Fig. 3C ). This variant was excluded from 100 control chromosomes and from the single-nucleotide polymorphism database (dbSNP 141) and the Exome variant server. The amino acid substitution affects the conserved arginine 463, in the β-propeller domain of integrin α3 and is predicted to be disease causing (PolyPhen2 score 1, Mutation Taster score 0.90). The tertiary structure of a sequence spanning amino acids 80-481 of wild-type and mutant integrin α3 was modeled (http://scratch.proteomics.ics.uci.edu/) (16), indicating that tryptophan at position 463 significantly alters the conformation of the β-propeller domain ( Fig. 3D and E) .
To explain the pathogenic role of the identified variant, we analyzed its consequences using patient's skin epithelial cells. Hence, keratinocytes were isolated from the skin biopsy of the patient and a healthy age-matched control, cultured and immortalized with the human papilloma virus genes E6E7, as described before (17) . Quantitative real-time PCR with RNA extracted from the subconfluent keratinocytes demonstrated that ITGA3 mRNA was ∼1.5-fold upregulated in the patient's cells compared with the control cells (Fig. 4A) , suggesting that the mutant integrin α3 polypeptide was expressed.
Integrin α3 is synthetized as a precursor of ∼150 kDa ( pre-α3A). After N-glycosylation in the endoplasmic reticulum (ER) and association with β1, the α3β1 heterodimer is transported in the Golgi, where processing of N-linked oligosaccharides occurs, and pre-α3A is cleaved into a heavy (115 kDa) and a light chain (35 kDa), which represent the mature form of the molecule (2) (Fig. 3E ). Immunoblot analysis using antisera 8-4 B7 which recognize both pre-α3A and the light chain (18) showed that in the patient's keratinocytes, only the precursor was present, but not the mature light chain (Fig. 4B ). We next determined the cell surface expression of the α3 and β1 integrin subunits in the patient's keratinocytes by flow cytometry. While no signal for integrin α3 was detected at the surface of the patient's keratinocytes, β1 was not significantly changed compared with the control cells, suggesting that it was still assembled, integrated into the membrane and activated (Fig. 4C ). In agreement with these findings, immunofluorescence staining demonstrated the absence of the mutant integrin α3 at vinculin-and integrin β1-positive focal adhesions and its accumulation in the cytoplasm (Fig. 4D ). These results demonstrate that mutant integrin α3 is synthetized as a precursor polypeptide, which is not cleaved and is not subsequently targeted to the cell membrane to fulfill its physiological functions. Notably, immunoprecipitation of α3 and β1 integrins showed no association between the mutant integrin α3 and the β1 subunit (Fig. 4F) .
In immunoblot under reducing conditions, wild-type pre-α3A appears as two bands (Figs 4B and 5A, D), which likely represent the high-mannose form in the ER, and the complex form after modification of the N-linked oligosaccharides in the Golgi apparatus (2) . We reasoned that the absence of the upper band observed in the patient's sample (Fig. 4B ) reflects a defect in glycosylation, after excluding a difference in the phosphorylation pattern (not shown). After treatment with N-glycanase (PNGase), an enzyme that cleaves between the innermost N-acetylglucosamine and asparagine residues of high mannose, hybrid and complex oligosaccharides from N-linked glycoproteins, deglycosylated wild-type and mutant pre-α3A migrated similarly (Fig 5A, left panel) . Treatment with tunicamycin, a pharmacological inhibitor of N-glycosylation, generated similar lower bands in both cell types (Fig. 5A, right panel, red arrow) ; the upper band, which was only present in the control sample and presumably represents a complex processed form, was not changed by this treatment (Fig. 5A, right panel) . These results suggest that mutant integrin α3 is N-glycosylated in ER, and that processing of N-linked oligosaccharides in Golgi is impaired, probably due to the influence of the protein conformation on N--linked oligosaccharide processing. Since the proteolytic processing of the heavy and light chains also takes place in the Golgi apparatus (19) , it seems likely that the misfolded mutant integrin α3 is either not properly transported from the ER to the Golgi or not further correctly processed in the Golgi. To address this, double immunofluorescence staining for integrin α3 and markers for either ER or Golgi was performed. In the Human
keratinocytes derived from the patient, we noticed cytoplasmic accumulation and partial co-localization of mutant integrin α3 with calnexin and single co-localization signals with Golgin-97 (Fig. 5B) . Hence, we cannot exclude a possible transport of the mutant integrin α3 from ER to Golgi. Moreover, both calnexin and Golgin-97 protein levels were increased in the patient compared with the control cells (Fig. 5C ). Calnexin is a chaperone protein that is involved in ER retention and folding of nascent glycoproteins. Both precursors, of α and β integrin subunits, undergo complex folding and associate with calnexin to ensure the proper conformation before the transport to the Golgi (20) . Golgin-97 is involved in early endosome/recycling endosometrans-Golgi network retrograde transport and has been proposed to tether early endosome/recycling endosome-derived vesicles (21) . The increased levels of calnexin and Golgin-97 observed in the patients' keratinocytes may reflect cellular responses to the abnormal processing and transport of the mutant integrin. In the attempt to evade quality control mechanisms in the ER and rescue the processing of the misfolded mutant integrin α3, the patient's cells were incubated with the chemical chaperone, 4-phenylbutyrate (4-PBA). However, this treatment did not induce the cleavage and formation of the mature light chain of mutant integrin α3 (Fig. 5D) .
Discussion
ILNEB is a rare autosomal recessive multiorgan disorder, first described in 2012 (1), which remains probably underrecognized. The clinical features consist of early onset interstitial lung disease, congenital nephrotic syndrome and skin fragility, but the full spectrum of clinical manifestations is still poorly characterized, and genotype−phenotype correlations are elusive. Here, we report on a case with solely interstitial lung disease and nephrotic syndrome and illuminate the underlying molecular defect. To the best of our knowledge, we disclosed a yet unreported homozygous ITGA3 mutation leading to an amino acid substitution in the extracellular β-propeller domain of integrin α3. In silico The consequences of the integrin α3 mutation p.R463W could not be easily anticipated. Intriguingly, in the same codon, another variant, c.1388G>A, p.R463Q is referenced in dbSNP 141 (rs185439534) with a very low minor allele frequency, of 0.0006. This could also represent a rare pathogenic variant, as suggested by in silico predictions (PolyPhen2 Score 1, Mutation Taster score 0.573). Our experimental results demonstrate that the mutant integrin α3 is expressed in the keratinocytes of the patient at levels comparable with the control cells, but the mutation prevents correct processing of N-linked oligosaccharides and maturation by cleavage into light and heavy chains in the Golgi. Consequently, authentic mutant integrin α3 accumulates in the cells, and is not targeted to the membrane. Intriguingly, in the patient's keratinocytes the β1 subunit, the physiological heterodimerization partner of α3, was detected on the surface by flow cytometry and visualized at focal adhesions by confocal microscopy, suggesting that when α3 is not functional and does not heterodimerize with β1, other αβ1 complexes are built and utilized (own unpublished data). In this respect, Margadant et al. have shown that integrin α6 forms heterodimers with β1 and compensates in part for the lack of integrin α3 (13), or α2 was proposed to compensate (22) , whereas in other models, neither of this was the case (23) .
In our case, blocking of ubiquitination and proteosomal degradation moderately increased the α3 amount in the patient's keratinocytes, at levels comparable with the control (not shown), suggesting that protein degradation does not significantly contribute to the disease mechanisms. Since 4-PBA has been shown to reduce protein mislocalization in diseases such as cystic fibrosis (24,25), we tested its effects on mutant integrin α3, but found no evidence for rescue of the defective processing of this particular mutant.
These findings point to the severe consequences of integrin α3 single amino acid substitutions and underline the critical role of folding and processing of integrins. The effects of two other integrin α3 amino acid substitutions (Fig. 3E) have been explored in recombinant systems (2, 4) . The mutation p.A349S was shown to induce gain of glycosylation and to disrupt heterodimerization and cell surface expression of α3β1. In mouse podocytes, in which the human mutation p.A349S was recombinantly expressed, α3 and β1 precursors accumulated in the ER and mutant α3 were ubiquitinated and proteosomally degraded (2) . The other missense mutation, p.R628P in the calf-1 domain of integrin α3 was expressed in A549 human lung adenocarcinoma cells; the experimental results raised the possibility that it induces conformational perturbations of the calf-1 domain that impairs the transport from the ER to the Golgi (4).
Regarding genotype−phenotype correlations, our patient had similar pulmonary findings with the cases that were reported before, but the severity of the renal and skin involvement was attenuated ( Table 1 ). The pulmonary findings support the diagnosis of an alveolar growth disorder in the subgroup of interstitial lung diseases. Because integrin α3 has been identified as a critical regulator of epithelial-mesenchymal transition and tissue remodeling in response to injury (10, 26) , recurrent lung infections and respiratory failure developed on the basis of distorted morphogenesis (8) characterized by impaired alveolarization seem to be the most common cause of death in these patients. Renal findings were different from the other reports, because our case has never necessitated peritoneal dialysis and renal failure did not develop during his clinical observation. Furthermore, abdominal ultrasonography showed crossed fused renal ectopia, a rare congenital malformation, in which both kidneys are located on the same side and are fused, with two separate ureters arising from the respective kidneys (27) . This finding strongly supports a recently published hypothesis that integrin α3 is not merely a passive anchor for renal extracellular matrix proteins, as predicted by mouse models, but is required for proper nephrogenesis (3). Finally, although there was no clinical evidence for cutaneous fragility, the analysis of a skin sample and of the keratinocytes of the patient, critically contributed to the elucidation of the molecular basis of the disease in our case.
Materials and Methods

Human tissues
After informed consent, skin and lung samples and EDTA-blood were obtained from the patient and from his parents, respectively. The study was approved by the Ethics Committee of the University of Freiburg.
Morphological analyses of the lung and the skin
For histopathological examination using light microscopy, lung and skin biopsy specimens were embedded in paraffin, and the sections were stained with hematoxylin and eosin by standard procedures. Indirect immunofluorescence staining of the patient's and control skin was performed on 5 μm cryosections, which were air dried and incubated with primary antibodies at 4°C overnight. For immunofluorescence antigen mapping, a panel of antibodies was used, as described before (1) . For integrin α3, the primary antibody P1B5 (Millipore, Darmstadt, Germany) was used. The secondary antibody was Alexa-488 anti-mouse IgG. Nuclei were stained with DAPI (Millipore, Temecula, CA, USA). Stained sections were observed with a confocal laserscanning microscope (LSM510, Carl Zeiss, Jena, Germany).
Cell culture and treatments
Normal skin specimens were obtained after informed written consent from an individual who underwent surgery, and used for isolation of cells. A part of the patient's skin obtained for diagnostic purposes was used to isolate keratinocytes, as described (28) . Keratinocyte cell lines were generated by immortalization with the HPV E6E7 genes (the construct is a kind gift of Dr Fernando Larcher) (17, 29) and cultured in keratinocyte growth medium (KGM) (Invitrogen, Karlsruhe, Germany).
Keratinocytes were incubated with KGM containing 1 µg/ml tunicamycin or only with KGM for 16 h (Sigma, Taufkirchen, Germany) before cell lysates were collected for the immunoblotting analysis. For the study of phosphorylation and glycosylation, cell lysates extracted from the control and patient keratinocytes were treated with 800 units lambda phosphatase (NEB, MA, USA) for 45 min at room temperature or with N-glycanase overnight in 37°C (PNGase, NEB); cell lysates were collected and analyzed by immunoblotting. In other sets of experiments, keratinocytes were cultured with 1-15 m 4-PBA (Sigma, Germany) for 48 h, with 100 n MG-132 (Calbiochem, La Jolla, CA, USA) for 6 h or with 200 µ p-tosyl--arginine methyl ester-HCl (TAME-HCL) (Sigma) for 1 h. After the indicated time points, cells were lysed as described below.
Immunofluorescence staining of cells
Cells were seeded on uncoated coverslips and allowed to grow for 2 days; thereafter, they were fixed and processed as described (17) . Primary antibodies were against: integrin α3 (8-4 B7, kind gift of Dr M. DiPersio), vinculin (7F9, Chemicon), β1 integrin (4B7R, Abcam), calnexin (Abcam) and Golgin-97 (Molecular Probes, Leiden, The Netherlands). The secondary antibodies were Alexa-488 anti-mouse IgG AND Alexa-594 anti-rabbit IgG (both Invitrogen, Darmstadt, Germany). Nuclei were visualized with DAPI. Images were captured by laser-scanning confocal microscopy (ZEN 2010, Carl Zeiss) or using immunofluorescence microscopy (Zeiss Axio Imager, Zeiss, Germany). The pictures were analyzed with the software ImageJ or ZEN 2012 black (3−4D analysis, visualization and measurement) (6) (Carl Zeiss).
Mutation detection and bioinformatics
Genomic DNA was extracted from EDTA-blood using QIAmp ® DNA mini kit (Qiagen, Hilden, Germany). Exon/intron boundaries of ITGA3 were amplified by PCR as described (1) . DNA sequences were compared with the reference sequence from NCBI Entrez Nucleotide database (ITGA3 NC_000017.11) using Mutation Surveyor™ DNA variant analysis software (version 2.61 Softgenetics, State College, PA, USA).
Prediction of the consequences of the sequence variants was performed with PolyPhen-2 (http://genetics.bwh.harvard.edu/ pph2/) and Mutation Taster (http://www.mutationtaster.org/).
Prediction of posttranslation modifications, glycosylation and phosphorylation were performed using http://www.cbs.dtu.dk/. Ubiquitination prediction was performed by using http://www. ubpred.org/. The tertiary structure of a sequence spanning amino acids 80-481 of wild-type and mutant integrin α3 was modeled using http://scratch.proteomics.ics.uci.edu (16) .
RNA extraction and qPCR
Total RNA was isolated from the keratinocytes of the patient and of a normal control using RNAeasy ® FFPE kit (Qiagen), transcribed into cDNA (Fermentas, St. Leon-Rot, Germany) and subjected to quantitative real-time PCR using iQ™ SYBR ® Green
Supermix and Biorad CFX96 Real-Time PCR Detection System (both Bio-Rad, Munich, Germany). Primers for ITGA3 were: forward-CTGGTGCTGTGTACCTGTGC and reverse-GCTGGTCTT CTGACCCTGAC. Primers for GAPDH were: forward-CGAGATC CCTCCAAAATCAA and reverse-TTCTAGACGGCAGGTCAGGT. The data were analyzed using the Bio-Rad CFX Manager Software (version 1.5).
Protein extraction and immunoblotting
Confluent cell monolayers were lysed with a buffer containing 25 m Tris−HCl, pH 7.5, 100 m NaCl, 1% NP-40, 1 m PEFABloc, 10 m EDTA and protease inhibitor cocktail (28) . For immunoblotting, equal amounts of proteins were separated on 8-10% SDS−PAGE under reducing conditions and immunoblotted. The membranes were incubated with primary antibodies overnight at 4°C, followed by incubation with secondary antibodies. Primary antibodies were against integrin α3 C-terminus (8-4 B7, kind gift of Dr M. DiPersio), calnexin (Abcam), Golgin-97 (Molecular Probes, Leiden, The Netherlands) and GAPDH (clone 6C5, Millipore) to control loading. Visualization followed with the ECL Plus system (Amersham) and the Fusion system (PeQlab, Germany).
Flow cytometry
For each analysis, 2 × 10 5 cells were trypsinized, washed twice with PBS and then incubated with the antibody P1B5 to detect integrin α3 and with 4B7R and 12G10 to detect β1 integrin at room temperature for 15 min. 4B7R was raised against the full-length human integrin β1 and detects the total protein amount. 12G10 has been shown to recognize a small sub-region of the βl subunit, residues 207-218, and detects the active conformation of β1 (30, 31) . After washing with PBS containing 1% BSA and 0.05% NaN 3 , the cells were incubated with FITC conjugated F(ab′) 2 goat anti-mouse IgG(H+C) antibody (Immunotech, PN, USA) for further 15 min. In a parallel experiment, isotype controls were used. Flow cytometry acquisition was performed using the BD FACSCalibur (BD Biosciences, Oxford, UK).
Coimmunoprecipitation
Coimmunoprecipitation assays were carried out using the Pierce ® Co-IP Kit (Rockford, IL, USA) with the antibodies 8-4 B7
to integrin α3 and clone JB1A to integrin β1 (Millipore), or the corresponding preimmune sera. The cell monolayers were lysed with the lysis buffer (0.025  Tris, 0.15  NaCl, 0.001  EDTA, 1% NP-40, 5% glycerol, pH 7.4). After centrifugation at 13 000g for 10 min, the supernatant was transferred to the resin and incubated at 4°C for 2 h. The samples were washed and eluted. The elution samples were resolved in SDS-PAGE and immunoblotted with 8-4 B7 to integrin α3 and JB1A to integrin β1. GAPDH was used as a loading control in the input.
